In the present work we develop a multiplex PCR assay for the detection and identification of the fish pathogen Vibrio vulnificus biotype 2 with discriminating potential for zoonotic strains (serovar E). The PCR assay allowed the identification of two new biotype 2 serovar E human isolates from culture collections. Finally, the multiplex was successfully applied to both diagnosis and carrier detection in field samples.Vibrio vulnificus is an aquatic bacterium from warm and tropical ecosystems, with pathogenic potential for humans and fish (mainly eels). Human vibriosis occurs after eating contaminated seafood or exposing open wounds to seawater (7,16,19), and fish vibriosis occurs after immersion in contaminated water or contact with diseased animals or carriers (2). The species is subdivided into three biotypes on the basis of differences in biochemical, genetic, and serological tests, as well as on the basis of the host range (4,20). At present, biotyping involves tedious and time-consuming tests (3, 4). For this reason, the clinical strains from fish are directly classified as biotype 2 (BT2), and those from humans as biotype 1, with the exception of the cellobiose-negative isolates from Israel, considered to be biotype 3.The first link between diseased fish manipulation and human diseases was established by Veenstra et al. in The Netherlands in 1992 (23). These authors hypothesized that diseased eels could constitute a risk for public health because the fish pathogen V. vulnificus BT2 could sporadically infect humans. The hypothesis was confirmed after the identification of one human isolate from the ATCC as belonging to BT2 and serovar E (BT2-SerE) (1). Although new human cases of vibriosis, acquired after fish manipulation, have been reported in northern Europe (5,6,9,14,22), none of these isolates has been identified at a subspecies level. These cases have been related to an increase in seawater temperature surrounding Baltic countries (water with salinity adequate for V. vulnificus survival) due to atypically warm years.The main objective of the present work was to develop a biotyping procedure based on a PCR assay that simplifies the identification of the V. vulnificus BT2 fish pathogen and, at the same time, allows for the discrimination of those isolates with human pathogenic potential (SerE). A secondary objective was to adapt the PCR protocol to vibriosis-diagnostic and -sensitive detection of the pathogen in subclinical carrier fish.For the design of the PCR primer sets, we selected the cytolisin gene vvhA, which is present in all V. vulnificus strains regardless of the biotype (13,24,25), and two DNA sequences specific for BT2 and SerE. These sequences were obtained from a study in which genomic DNA of eel-virulent and of eel-avirulent strains of different biotypes was compared by suppression subtractive hybridization (15). The BT2-specific sequences could be considered virulence markers since they are present only in the fish-virulent strains (15). Table 1 shows the sequences of the three primer p...